A protocol for intravenous pentamidine administration

Pentamidine isethionate has been approved by the Food and Drug Administration as a treatment for Pneumocystis carinii pneumonia, the most common opportunistic infection associated with acquired immunodeficiency syndrome. This article outlines the protocol for intravenous administration of pentamidine isethionate in use at The Mount Sinai Medical Center in New York.